ALK-Abello A/S AKBLF:OTCPK

*Data is delayed | Exchange | USD
Last | 04/19/24 EDT
17.90UNCH (UNCH)
52 week range
8.20 - 19.90
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close17.90
  • 52 Week High19.90
  • 52 Week High Date02/20/24
  • 52 Week Low8.20
  • 52 Week Low Date07/07/23

Key Stats

  • Market Cap3,968.85M
  • Shares Out221.19M
  • 10 Day Average Volume139
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close17.90
  • 52 Week High19.90
  • 52 Week High Date02/20/24
  • 52 Week Low8.20
  • 52 Week Low Date07/07/23
  • Market Cap3,968.85M
  • Shares Out221.19M
  • 10 Day Average Volume139
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)0.31
  • P/E (TTM)57.75
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/03/2024
  • Ex Div Date03/15/2017
  • Div Amount5.00
  • Split Date-
  • Split Factor-

Latest On ALK-Abello A/S

 

Profile

MORE
ALK-Abello A/S is a Denmark-based company active within the pharmaceutical industry. It is engaged in the development and marketing of pharmaceutical products for the treatment, prevention and diagnosis of allergy. Its product portfolio comprises allergy vaccines, emergency treatments and allergy diagnostics products. The Company’s allergy vaccines product offering comprises tablet vaccines, sublingual vaccines and subcutaneous vaccines. Its emergency treatments product...
Lene Skole- Soerensen
Vice Chairman of the Board
Anders Hedegaard
Independent Chairman of the Board
Peter Halling
President, Chief Executive Officer
Claus Solje
Executive Vice President, Chief Financial Officer
Soeren Niegel
Executive Vice President - Commercial Operations
Address
Boege Alle 6-8
Hoersholm
2970
Denmark